Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy…
Combining two diabetes medications protects the heart better than either one alone, offering people real cardiovascular benefits alongside their blood sugar control.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
MRDsteer: quality-aware AI-driven closed-loop optimization enhances…
Smart AI monitoring of blood cancer DNA tests catches early warning signs more reliably, helping doctors spot recurrence sooner when treatment may work best.
Near-term implementable findingBlood Biochemistry Age Clock - an interpretable estimate of…
A simple blood test from routine checkups now estimates your biological aging speed, offering an interpretable window into how your body is aging compared to your calendar age.
Standard additionDifferences in the prevalence and patterns of dementia risk factors…
Dementia risk factors vary widely across countries, but consistent patterns suggest tailored prevention programs combining universal strategies with locally relevant approaches can work everywhere.
Novel or significantly improved treatmentBaseline peripheral blood immune markers associated with clinical…
A simple blood count before starting advanced breast cancer treatment might identify who will benefit most, helping doctors match patients with therapies they're likely to respond to.